Clinical Trial Update: 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 18F-PSMA PET/MRI for diagnosing clinically significant prostate cancer has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN